Kerry Group set to acquire Biosearch Life

By Jim Cornall contact

- Last updated on GMT

Biosearch Life operates in the nutraceutical and functional food sectors.  Pic: Getty Images/sarayut
Biosearch Life operates in the nutraceutical and functional food sectors. Pic: Getty Images/sarayut

Related tags: Biosearch Life, Kerry, Kerry Group, M&A

Kerry Group plc has announced its intention to acquire the Spanish company Biosearch Life.

Based in Granada, Spain, and with a staff of more than 150, Biosearch Life is active in the nutraceutical and functional food sectors. The company has a range of probiotics including in premium probiotics obtained from human breast milk (the Hereditum brand), scientifically backed botanical extracts (Exxentia) and natural omega-3 (the Eupoly-3 brand).

The acquisition is envisaged to be completed by means of a friendly public tender offer for the shares of Biosearch Life addressed to all of its shareholders, and is subject to the prior approval of the Spanish National Securities Markets Commission and, upon its approval, to the acceptance of the offer by Biosearch Life's shareholders.

Grupo Lactalis Iberia, S.A., main shareholder of Biosearch Life, has irrevocably undertaken to tender its entire stake representing 29.5% of the share capital of the company into the offer.

Related topics: Manufacturers

Related news


Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us


View more